Metropolitan Life Insurance Company (MetLife)’s CTS Corp CTS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CTS Stock Details CTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,633	Closed	-$76.4K	–	532
2024 Q1	$76.4K	Sell	1,633 -151	-8%	-$6.62K	﹤0.01%	1197
2023 Q4	$78K	Hold	1,784	–	–	﹤0.01%	1214
2023 Q3	$74.5K	Hold	1,784	–	–	﹤0.01%	1176
2023 Q2	$76.1K	Hold	1,784	–	–	﹤0.01%	1170
2023 Q1	$88.2K	Sell	1,784 -158	-8%	-$7.07K	﹤0.01%	1056
2022 Q4	$76.6K	Buy	1,942 +104	+6%	+$4.28K	﹤0.01%	1214
2022 Q3	$76.6K	Hold	1,838	–	–	﹤0.01%	1177
2022 Q2	$62.6K	Sell	1,838 -338	-16%	-$12.3K	﹤0.01%	1351
2022 Q1	$76.9K	Sell	2,176 -6,588	-75%	-$230K	﹤0.01%	1365
2021 Q4	$322K	Hold	8,764	–	–	﹤0.01%	1703
2021 Q3	$271K	Hold	8,764	–	–	﹤0.01%	1854
2021 Q2	$326K	Buy	8,764 +810	+10%	+$27.9K	﹤0.01%	1795
2021 Q1	$247K	Sell	7,954 -489	-6%	-$16.1K	﹤0.01%	1868
2020 Q4	$290K	Sell	8,443 -1,768	-17%	-$52.3K	﹤0.01%	1694
2020 Q3	$225K	Sell	10,211 -578	-5%	-$12.1K	﹤0.01%	1704
2020 Q2	$216K	Hold	10,789	–	–	﹤0.01%	1745
2020 Q1	$269K	Buy	10,789 +500	+5%	+$13.6K	0.01%	1413
2019 Q4	$309K	Sell	10,289 -495	-5%	-$14.3K	﹤0.01%	1622
2019 Q3	$349K	Hold	10,784	–	–	0.01%	1516
2019 Q2	$297K	Hold	10,784	–	–	0.01%	1627
2019 Q1	$317K	Hold	10,784	–	–	0.01%	1593
2018 Q4	$279K	Hold	10,784	–	–	0.01%	1592
2018 Q3	$370K	Hold	10,784	–	–	0.01%	1586
2018 Q2	$388K	Hold	10,784	–	–	0.01%	1494
2018 Q1	$293K	Hold	10,784	–	–	﹤0.01%	1632
2017 Q4	$278K	Sell	10,784 -11,747	-52%	-$309K	﹤0.01%	1678
2017 Q3	$543K	Hold	22,531	–	–	﹤0.01%	1644
2017 Q2	$487K	Hold	22,531	–	–	﹤0.01%	1712
2017 Q1	$480K	Hold	22,531	–	–	﹤0.01%	1672
2016 Q4	$505K	Hold	22,531	–	–	﹤0.01%	1724
2016 Q3	$419K	Sell	22,531 -1,492	-6%	-$28.2K	﹤0.01%	1811
2016 Q2	$430K	Hold	24,023	–	–	﹤0.01%	1798
2016 Q1	$378K	Hold	24,023	–	–	﹤0.01%	1759
2015 Q4	$424K	Buy	24,023 +2,361	+11%	+$44.1K	﹤0.01%	1730
2015 Q3	$401K	Sell	21,662 -4,730	-18%	-$88.6K	﹤0.01%	1778
2015 Q2	$509K	Sell	26,392 -1,405	-5%	-$25.9K	﹤0.01%	1732
2015 Q1	$500K	Sell	27,797 -262	-0.9%	-$4.45K	﹤0.01%	1560
2014 Q4	$500K	Hold	28,059	–	–	﹤0.01%	1762
2014 Q3	$446K	Hold	28,059	–	–	﹤0.01%	1786
2014 Q2	$525K	Hold	28,059	–	–	﹤0.01%	1797
2014 Q1	$586K	Hold	28,059	–	–	﹤0.01%	1695
2013 Q4	$559K	Hold	28,059	–	–	﹤0.01%	1733
2013 Q3	$442K	Hold	28,059	–	–	﹤0.01%	1830
2013 Q2	$383K	Buy	+28,059	New	+$317K	﹤0.01%	1875

Other funds holding CTS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CTS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CTS Corp (CTS) in Q2 2024, closing a stake of 1,633 shares — an estimated $76.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CTS in Q2 2013 and held it in 44 quarters. The position peaked at $586K in Q1 2014. 210 funds tracked by Wall St. Rank hold CTS as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining CTS Corp position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,633 CTS Corp shares in Q2 2024, an estimated $76.4K.
Metropolitan Life Insurance Company (MetLife) first reported a position in CTS Corp in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s CTS Corp position peaked at $586K in Q1 2014.
210 funds tracked by Wall St. Rank held CTS Corp as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.